Page last updated: 2024-10-22

tyrphostin ag957 and B-Cell Chronic Lymphocytic Leukemia

tyrphostin ag957 has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies

tyrphostin AG957: tyrosine kinase blocker; structure given in first source

Research Excerpts

ExcerptRelevanceReference
"Adaphostin (NSC 680410), an analog of the tyrphostin AG957, was previously shown to induce Bcr/abl down-regulation followed by loss of clonogenic survival in chronic myelogenous leukemia (CML) cell lines and clinical samples."3.72Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells. ( Adjei, AA; Bone, N; Bruzek, LM; Chandra, J; Hackbarth, J; Karp, JE; Kaufmann, SH; Kay, NE; Le, S; Loegering, D; Narayanan, VL; Sausville, EA; Tefferi, A, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chandra, J1
Hackbarth, J1
Le, S1
Loegering, D1
Bone, N1
Bruzek, LM1
Narayanan, VL1
Adjei, AA1
Kay, NE1
Tefferi, A1
Karp, JE1
Sausville, EA1
Kaufmann, SH1

Other Studies

1 other study available for tyrphostin ag957 and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells.
    Blood, 2003, Dec-15, Volume: 102, Issue:13

    Topics: Acetylcysteine; Adamantane; Antioxidants; Apoptosis; Buthionine Sulfoximine; DNA Damage; DNA, Neopla

2003